The role of steroid hormones in the regulation of vasopressin and oxytocin release and mRNA expression in hypothalamoneurohypophysial explants from the rat

Experimental Physiology

Volumn 85 S, Issue SPEC. ISS., 2000, Pages

  Sladek, Celia D ^a   Swenson, Kerry L ^a   Kapoor, Roger ^a   Sidorowicz, Hanna E ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANDROSTANOLONE; CORTICOSTERONE; ESTRADIOL; GLUTAMATE RECEPTOR ANTAGONIST; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXYTOCIN; SEX HORMONE; TESTOSTERONE; VASOPRESSIN;

ANIMAL TISSUE; CONTROLLED STUDY; GIANT CELL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NONHUMAN; OSMOLALITY; OXYTOCIN RELEASE; RAT; REVIEW; SUPRAOPTIC NUCLEUS; SYNAPSE; VASOPRESSIN RELEASE;

EID: 0034027153     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-445x.2000.tb00021.x     Document Type: Review

References (53)

1. AMICO, J. A., SEIF, S. M. & ROBINSON, A. G. (1981). Elevation of oxytocin and the oxytocin-associated neurophysin in the plasma of normal women during midcycle. Journal of Clinical Endocrinology and Metabolism 53, 1229-1232.
2. ARONICA, S. M., KRAUS, W. L. & KATZENELLENBOGEN, B. S. (1994). Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulaled gene transcription. Proceedings of the National Academy of Sciences of the USA 91, 8517-8521.
3. BERGHORN, K. A., KNAPP, L. T., HOFFMAN, G. E. & SHERMAN, T. G. (1995). Induction of glucocorticoid receptor expression in hypothalamic magnocellular vasopressin neurons during chronic hypoosmolality. Endocrinology 136, 804-811.
4. BISSET, G. W. & CHOWDREY. H. S. (1988). Control of release of vasopressin by neuroendocrine reflexes. Quarterly Journal of Experimental Physiology 73, 811-872.
5. BOURQUE, C. W., OLIET, S. H. R. & RICHARD, D. (1994). Osmoreceptors, osmoreception, and osmoregulation. Frontiers in Neuroendocrinolology 15, 231-274.
6. CROFTON, J. T., BAER, P. G., SHARE, L. & BROOKS, D. P. (1985). Vasopressin release in male and female rats: Effects of gonadectomy and treatment with gonadal steroid hormones. Endocrinology 117, 1195-1200.
7. CROFTON, J. T. & SHARE, L. (1989). Osmotic control of vasopressin in male and female rats. American Journal of Physiology 257, R738-743.
8. CROWLEY, R. S. & AMICO, J. A. (1993). Gonadal steroid modulation of oxytocin and vasopressin gene expression in the hypothalamus of the osmotically stimulated rat. Endocrinology 133, 2711-2718.
9. DURR, J. A., STAMOUTSOS, B. & LINDHEIMER, M. D. (1981). Osmoregulation during pregnancy in the rat: Evidence for resetting of the threshold for vasopressin secretion during gestation. Journal of Clinical Investigation 68, 337-346.
10. FORSLING, M. L. AKERLUND, M. & STROMBERG, P. (1981). Variations in plasma concentrations of vasopressin during the menstrual cycle. Journal of Endocrinology 89, 263-266.
11. FORSLING, M. L. & PEYSNER, K. (1988). Pituitary and plasma vasopressin concentrations and fluid balance throughout the oestrous cycle of the rat. Journal of Endocrinology 117, 397-402.
12. FORSLING, M. L., STROMBERG, P. & AKERLUND, M. (1982). Effect of ovarian steroids on vasopressin secretion. Journal of Endocrinology 95, 147-151.
13. GOODMAN, Y., BRUCE, A. J., CHENG, B. & MATTSON, M. P. (1996). Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptidc toxicity in hippocampal neurons. Journal of Neurochemistry 66, 1836-1844.
14. GU, Q. & MOSS, R. L. (1996). 17b-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. Journal of Neuroscience 16, 3620-3629.
15. 3 subunits on supraoptic oxytocin neurones. Journal of Neuroendocrinology 6, 5-11.
16. KOSTOGLOU-ATHANASSIOU, I., ATHANASSIOU, P., TREACHER, D. F., WHEELER, M. J. & FORSLING, M. L. (1998). Neurohypophyseal homone and melatonin secretion over the natural and suppressed menstrual cycle in premenopausal women. Clinical Endocrinology 49, 209-216.
17. LI, X., SCHWARZ, P. E. & RISSMAN, E. F. (1997). Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. Neuroendocrinology 66, 63-67.
18. LIU, X. & CHEN, Y.-Z. (1995). Membrane-mediated inhibition of corticosterone on the release of arginine vasopressin from rat hypothalamic slices. Brain Research 704, 19-22.
19. LIU, X., WANG, C.-A. & CHEN, Y.-Z. (1995). Nongenomic effect of glucocorticoid on the release of arginine vasopressin from hypothalamic slices in rats. Neuroendocrinology 62, 628-633.
20. MCEWEN, B. S. (1991). Non-genomic and genomic effects of steroids on neural activity. Trends in Pharmacological Science 12, 141-146.
21. A receptor. Mechanism of action and physiological significance. Progress in Neurobiology 38, 379-395.
22. 125I-labeled BSA by female rat liver. Biology of Reproduction 58, 531-538.
23. NAFTOLIN, F., RYAN, K. J., DAVIES, I. J., REDDY, V. V., FLORES, F., PETOR, Z., KUHN, M., WHITE, R. J., TAKOAKOA, Y. & WOLIN, L. (1975). The formation of estrogens by central neuroendocrine tissues. Recent Progress in Hormone Research 32, 295-319.
24. PAPANEK, P. E., SLADEK, C. D. & RAFF, H. (1997). Corticosterone inhibition of osmotically-stimulated vasopressin release from hypothalamic-neurohypophysial explants. American Journal of Physiology 272, R158-162.
25. PAPPAS, T. C., GAMETCHU, B. & WATSON, C. S. (1995). Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB Journal 9, 404-410.
26. PEYSNER, K. & FORSLING, M. L. (1990). Effect of ovariectomy and treatment with ovarian steroids on vasopressin release and fluid balance in the rat. Journal of Endocrinology 124, 277-284.
27. PUNNONEN, R., VIINAMAKI, O. & MULTAMAKI, S. (1983). Plasma vasopressin during normal menstrual cycle. Hormone Research 17, 90-92.
28. RAFF, H. (1993). Interactions between neurohypophysial hormones and the ACTH-adrenocortical axis. Annals of the New York Academy of Sciences 689, 411-425.
29. RICHARD, D. & BOURQUE, C. W. (1995). Synaptic control of rat supraoptic neurones during osmotic stimulation of the organum vasculosum lamina terminalis in vitro. Journal of Physiology 489, 567-577.
30. ROSELLI, C. E., HORTON, L. E. & RESKO, J. A. (1985). Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system. Endocrinology 117, 2471-2477.
31. SHARE, L., WANG, Y.-X. & CROFTON, J. T. (1995). Gender differences in the actions of vasopressin. In Neurohypophysis: Recent Progress in Vasopressin and Oxytocin Research, ed. SAITO, T., KUROKAWA, K. & YOSHIDA, S., pp. 3-13. Elsevier Science B.V., Amsterdam.
32. SHUGHRUE, P. J., KOMM, B. & MERCHENTHALER, I. (1996). The distribution of estrogen receptor-β mRNA in the rat hypothalamus. Steroids 61, 678-681.
33. SINGH, M., SETALO, G., JR., GUAN, Z., WARREN, M. & TORANALLERAND, C.D. (1999). Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways. Journal of Neuroscience 19, 1179-1188.
34. SKOWSKY, W. R., SWAN, L., SMITH, P. (1979). Effects of sex steroid hormones on arginine vasopressin in intact and castrated male and female rats. Endocrinology 104, 105-108.
35. SLADEK, C. D., BADRE, S. E., MORSETTE, D. J. & SIDOROWICZ, H. E. (1998). Role of non-NMDA receptors in osmotic and glutamate stimulation of vasopressin release: Effect of rapid receptor desensitization. Journal of Neuroendocrinology 10, 897-903.
36. SLADEK, C. D., FISHER, K. Y., SIDOROWICZ, H. E. & MATHIASEN, J. R. (1995). Osmotic stimulation of vasopressin mRNA content in the supraoptic nucleus requires synaptic activation. American Journal of Physiology 268, R1034-1039.
37. SLADEK, C. D. & JOHNSON, A. K. (1983). The effect of anteroventral third ventricle lesions on vasopressin release by organ cultured hypothalamo-neurohypophyseal explants. Neuroendocrinology 37, 78-84.
38. SPRUCE, B. A., BAYLIS, P. H., BURD, J. & WATSON, M. J. (1985). Variation in osmoregulation of arginine vasopressin during the human menstrual cycle. Clinical Endocrinology 11, 37-42.
39. STACHENFELD, N. S., DIPIETRO, L., KOKOSZKA, C. A., SILVA, C., KEEFE, D. L. & NADEL, E. R. (1999). Physiological variability of fluid-regulation hormones in young women. Journal of Applied Physiology 86, 1092-1096.
40. STONE, J. D., CROFTON, J. T. & SHARE, L. (1989). Sex differences in central adrenergic control of vasopressin release. American Journal of Physiology 257, R1040-1045.
41. STONE, J. D., CROFTON, J. T. & SHARE, L. (1991). Sex differences in central adrenoreceptor-mediated vasopressin response to hemorrhage. American Journal of Physiology 260, E780-786.
42. SWENSON, K. L. & SLADEK, C. D. (1997). Gonadal steroid modulation of vasopressin secretion in response to osmotic stimulation. Endocrinology 138, 2089-2097.
43. SWENSON, K. L., BADRE, S. E., MORSETTE, D. J. & SLADEK, C. D. (1998). N-methyl-D-aspartic (NMDA) stimulation of vasopressin release: Role in osmotic regulation and modulation by gonadal steroids. Journal of Neuroendocrinology 10, 679-685.
44. TRIGOSO, W. F., WESLY, J. M. MERANDA, D. L. & SHENKER, Y. (1996). Vasopressin and atrial natriuretic hormone response to hypertonic saline during the follicular and luteal phases of the menstrual cycle. Human Reproduction 11, 2392-2395.
45. VOKES, T. J., WEISS, N. J., SCHREIBER, J., GASKILL, M. B. & ROBERTSON, G. L. (1988). Osmoregulatin of thirst and vasopressin during normal menstrual cycle. American Journal of Physiology 254, R641-647.
46. WAGNER, C. K. & MORRELL, J. I. (1996). Distribution and steroid hormone regulation of aromatase mRNA expression in the forebrain of adult male and female rats: A cellular-level analysis using in situ hybridization. Journal of Comparative Neurology 370, 71-84.
47. WATANABE, H., LAU, D. C., GUYN, H. L. & WONG, N. L. (1997). Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome. Clinical Investigations Medicine 10, 211-223.
48. WEAVER, C. E., PARK-CHUNG, M., GIBBS, T. T. & FARB, D. H. (1997). 17b-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Research 761, 338-341.
49. WILLIAMS, T. D. M., EDWARDS, A., FAIRHALL, K. M., ROBINSON, I. C. A. F., MCGARRICK, G. M. & LIGHTMAN, S. L. (1985). Influence of endogenous and exogenous oestrogens on posterior pituitary secretion in women. Clinical Endocrinology 22, 589-596.
50. WINDLE, R. J. & FORSLING, M. L. (1993). Variations in oxytocin secretion during the 4-day oestrous cycle of the rat. Journal of Endocrinology 136, 305-311.
51. WOOLLEY, C. S. & SCHWARTZCROIN, P. A. (1998). Hormonal effects on the brain. Epilepsia 39, S8:S2-S8.
52. ZHOU, L., BLAUSTEIN, J. D. & DE VRIES, G. J. (1994). Distribution of androgen receptor immunoreactivity in vasopressin-and oxytocin-immunoreactive neurons in the male rat brain. Endocrinology 134, 2622-2627.
53. ZINGG, H. H., GRAZZINI, E., BRETON, C., LARCHER, A., ROZEN, F., RUSSO, C., GUILLON, G. & MOULLIAC, B. (1998). Genomic and non-genomic mechanisms of oxytocin receptor regulation. Advances in Experimental Medicine and Biology 449, 287-295.